Synergy Pharmaceuticals said its drug to treat idiopathic constipation met the main goal in a late-stage trial, sending its shares up as much as 67 percent to a four-year high.
Business briefing: Constipation Drug Succeeds in Late-Stage Trial
Synergy Pharmaceuticals said its drug to treat idiopathic constipation met the main goal in a late-stage trial, sending its shares up as much as 67 percent to a four-year high.
No comments:
Post a Comment